Skip to content
Recall Observatory FDA recall evidence

Drug product

Sermorelin 6mg/6mL Lyophilized Powder, Sterile Compound for Subcutaneous Injection, Diabetes Corporation of America dba DCA Pharmacy, Franklin, TN 37064-5527

D-0006-2016

September 23, 2015

Class II

Product summary

Firm
Diabetes Corporation of America dba DCA Pharmacy
Event
Event 72271
Status
Terminated
Classification
Class II
Quantity
129 vials
Official record key
drug-enforcement:D-0006-2016

Official wording

Reason: Lack of Assurance of Sterility: A recent FDA inspection found that this product was not being compounded in an area appropriate for lyophilization which may lead to a lack of sterility assurance.

Code information: Lot #: 101614, Exp 4/30/2015

Distribution pattern: KY, OH, TN

Derived failure modes

  • Sterility assurance

    reason.sterility_assurance · v1.0.0

    Lack of Assurance of Sterility